Scarring Alopecia Associated With Use of the Epidermal Growth Factor Receptor Inhibitor Gefitinib

被引：24
|
作者：
Donovan, Jeffrey C.
Ghazarian, Danny M.
Shaw, James C.
机构：
来源：
ARCHIVES OF DERMATOLOGY | 2008年 / 144卷 / 11期
关键词：
D O I：
10.1001/archderm.144.11.1524
中图分类号：
R75 [皮肤病学与性病学];
学科分类号：
100206 ;
摘要：
引用
收藏
页码：1524 / 1525
页数：2
相关论文
共 50 条
  • [1] Scarring alopecia secondary to epidermal growth factor inhibitor Gefitinib
    Donovan, J.
    Ghazarian, D.
    Shaw, J.
    JOURNAL OF CUTANEOUS PATHOLOGY, 2008, 35 (01) : 101 - 101
  • [2] Scarring alopecia associated with the epidermal growth factor receptor inhibitor erlotinib
    Hepper, Donna M.
    Wu, Peggy
    Anadkat, Milan J.
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2011, 64 (05) : 996 - 998
  • [3] Nonscarring inflammatory alopecia associated with the epidermal growth factor receptor inhibitor gefitinib
    Graves, Julia E.
    Jones, Beverly F.
    Lind, Anne C.
    Heffernan, Michael P.
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2006, 55 (02) : 349 - 353
  • [4] A case report of inflammatory nonscarring alopecia associated with the epidermal growth factor receptor inhibitor erlotinib
    Pongpudpunth, Marinya
    Demierre, Marie France
    Goldberg, Lynne J.
    JOURNAL OF CUTANEOUS PATHOLOGY, 2009, 36 (12) : 1303 - 1307
  • [5] A case report of inflammatory nonscarring alopecia associated with the epidermal growth factor receptor inhibitor erlotinib
    Pongpudpunth, M.
    Goldberg, L.
    JOURNAL OF CUTANEOUS PATHOLOGY, 2008, 35 (01) : 116 - 116
  • [6] Effects of Gefitinib, an Epidermal Growth Factor Receptor Inhibitor, on Human Placental Cell Growth
    Nilsson, Ulrika W.
    Johns, Terrance G.
    Wilmann, Tania
    Kaitu'u-Lino, Tu'uhevaha
    Whitehead, Clare
    Dimitriadis, Eva
    Menkhorst, Ellen
    Saglam, Burcu
    Gao, Yane
    Greenall, Sameer A.
    Horne, Andrew W.
    Tong, Stephen
    OBSTETRICS AND GYNECOLOGY, 2013, 122 (04): : 737 - 744
  • [7] Paronychia induced by Gefitinib, an epidermal growth factor receptor tyrosine kinase inhibitor
    Nakano, J
    Nakamura, M
    JOURNAL OF DERMATOLOGY, 2003, 30 (03): : 261 - 262
  • [8] Tumor penetration of gefitinib (Iressa), an epidermal growth factor receptor tyrosine kinase inhibitor
    McKillop, D
    Partridge, EA
    Kemp, JV
    Spence, MP
    Kendrew, J
    Barnett, S
    Wood, PG
    Giles, PB
    Patterson, AB
    Bichat, F
    Guilbaud, N
    Stephens, TC
    MOLECULAR CANCER THERAPEUTICS, 2005, 4 (04) : 641 - 649
  • [9] Pharmacokinetics of gefitinib, an epidermal growth factor receptor tyrosine kinase inhibitor, in rat and dog
    McKillop, D
    Partridge, EA
    Hutchison, M
    Rhead, SA
    Parry, AC
    Bardsley, J
    Woodman, HM
    Swaisland, HC
    XENOBIOTICA, 2004, 34 (10) : 901 - 915
  • [10] Bioactivation of the Epidermal Growth Factor Receptor Inhibitor Gefitinib: Implications for Pulmonary and Hepatic Toxicities
    Li, Xiaohai
    Kamenecka, Theodore M.
    Cameron, Michael D.
    CHEMICAL RESEARCH IN TOXICOLOGY, 2009, 22 (10) : 1736 - 1742
12345